A Breakthrough in Distinguishing Benign Adrenal Tumors from Cancerous Ones

Mayo Clinic Laboratories is pleased to announce it has been selected as a UnitedHealthcare Preferred Lab Network (PLN) care provider. Under the agreement, effective July 1, 2019, UnitedHealthcare members have in-network access to Mayo Clinic Laboratories’ comprehensive subspecialty testing menu.

This week’s research roundup features an assessment of the predictive value of outpatient smartphone videos for diagnosis of epileptic seizures.

PACE / State of CA / State of FL
In this month’s “Virtual Lecture,” Colin West, M.D., Ph.D., speaks broadly about health care professionals' well-being, and discusses various principles for you to use in your own career to prevent burnout symptoms and dissatisfaction.

Every week, Mayo Clinic microbiologist Bobbi Pritt, M.D., posts a new Parasite Wonders case. The specimen below was submitted by a young woman who found this "worm" by her arm, right below her mouth, upon waking from a nap. What's the identification?

This week’s research roundup features a study on how abnormal expression of programmed death-1 (PD-1) ligand-1(PD-L1) in cancer cells play a crucial role in cancer immune evasion and progression.

Irina Bancos, M.D. gives an overview of this test available through Mayo Clinic Laboratories. She discusses when this testing should be ordered, how this testing compares to other testing approaches, and what clinical action can be taken due to the results of this testing.

As a pioneer in the field, the Mayo Clinic plays an integral role by discovering new tests and treatments for plasma cell disorders. Our algorithmic approach ensures that the right tests are ordered at the right time, and that health care providers get clinically actionable answers for their patients faster. And testing with Mayo Clinic means 24/7 access to our physician and laboratory experts, who are leaders in their field.